Evidence map›Paper›PMID 26090671›Full record

ArticlePloS one2015

Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis.

Violeta Lorén, Eduard Cabré, Isabel Ojanguren, Eugeni Domènech, Elisabet Pedrosa, Arce García-Jaraquemada, Miriam Mañosa, Josep Manyé

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Prednisolone Targets Claudins in Mouse Brain Blood Vessels.International journal of molecular sciences · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Link between Gut Dysbiosis Caused by a High-Fat Diet and Hearing Loss.International journal of molecular sciences · 2021
    Review
  14. Review
  15. Article
  16. COVID-19-associated diarrhea.World journal of gastroenterology · 2021
    Review
  17. Review
  18. Biology and therapeutic potential of interleukin-10.The Journal of experimental medicine · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Violeta LorénInflammatory Bowel Disease Unit, Research Institute of Health Sciences 'Germans Trias i Pujol', Badalona, Barcelona, Spain; CIBER, Madrid, Spain.
Eduard CabréCIBER, Madrid, Spain; Inflammatory Bowel Disease & G-I Unit, Department of Gastroenterology, 'Germans Trias i Pujol' University Hospital, Badalona, Barcelona, Spain.
Isabel OjangurenDepartment of Pathology, 'Germans Trias i Pujol' University Hospital, Badalona Barcelona, Spain.
Eugeni DomènechCIBER, Madrid, Spain; Inflammatory Bowel Disease & G-I Unit, Department of Gastroenterology, 'Germans Trias i Pujol' University Hospital, Badalona, Barcelona, Spain.
Elisabet PedrosaInflammatory Bowel Disease Unit, Research Institute of Health Sciences 'Germans Trias i Pujol', Badalona, Barcelona, Spain; CIBER, Madrid, Spain.
Arce García-JaraquemadaInflammatory Bowel Disease Unit, Research Institute of Health Sciences 'Germans Trias i Pujol', Badalona, Barcelona, Spain.
Miriam MañosaCIBER, Madrid, Spain; Inflammatory Bowel Disease & G-I Unit, Department of Gastroenterology, 'Germans Trias i Pujol' University Hospital, Badalona, Barcelona, Spain.
Josep ManyéInflammatory Bowel Disease Unit, Research Institute of Health Sciences 'Germans Trias i Pujol', Badalona, Barcelona, Spain; CIBER, Madrid, Spain.
Hospital Universitari Germans Trias i Pujol · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESResearch Institute of Health Sciences · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucocorticosteroids are the first line therapy for moderate-severe flare-ups of ulcerative colitis. Despite that, up to 60% of patients do not respond adequately to steroid treatment. Previously, we reported that low IL-10 mRNA levels in intestine are associated with a poor response to glucocorticoids in active Crohn's disease. Here, we test whether IL-10 can favour the response to glucocorticoids by improving the TNFα-induced intestinal barrier damage (assessed by transepithelial electrical resistance) in Caco-2 monolayers, and their possible implications on glucocorticoid responsiveness in active ulcerative colitis. We show that the association of IL-10 and glucocorticoids improves the integrity of TNFα-treated Caco-2 cells and that p38 MAPK plays a key role. In vitro, IL-10 facilitates the nuclear translocation of p38 MAPK-phosphorylated thereby modulating glucocorticoids-receptor-α, IL-10-receptor-α and desmoglein-2 expression. In glucocorticoids-refractory patients, p38 MAPK phosphorylation and membrane desmoglein-2 expression are reduced in colonic epithelial cells. These results suggest that p38 MAPK-mediated synergism between IL-10 and glucocorticoids improves desmosome straightness contributing to the recovery of intestinal epithelium and reducing luminal antigens contact with lamina propria in ulcerative colitis. This study highlights the link between the intestinal epithelium in glucocorticoids-response in ulcerative colitis.

Indexed as

Active Transport, Cell NucleusAdrenal Cortex HormonesBiopsyCaco-2 CellsColitis, UlcerativeDesmoglein 2Drug SynergismEpithelial CellsGene Expression RegulationGlucocorticoidsHumansInterleukin-10Intestinal Mucosap38 Mitogen-Activated Protein KinasesPhosphorylationReceptors, GlucocorticoidAdrenal Cortex HormonesDesmoglein 2glucocorticoid receptor alphaGlucocorticoidsInterleukin-10p38 Mitogen-Activated Protein KinasesReceptors, GlucocorticoidReceptors, Interleukin-10Tumor Necrosis Factor-alpha

Identifiers

PMID26090671
PMCPMC4474693
OpenAlexW1547985966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.